chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Redness; sweats; Inflamed sorearm; headache; Extreme fatigue; Inflamed sorearm; chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71 year-old female patient (unknown if pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 18Feb2021 08:30 (Lot number: EL9267) at the age of 71 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (At 11:30, Dose 1 (Lot/Batch number: EL9262).), administration date: 25Jan2021, for covid-19 immunisation, reaction(s): "Swelling", "Redness", "soreness down to the elbow". The following information was reported: HEADACHE (non-serious) with onset 18Feb2021 17:00, outcome "recovered" (20Feb2021), described as "headache"; FATIGUE (non-serious) with onset 18Feb2021 17:00, outcome "recovered" (20Feb2021), described as "Extreme fatigue"; PERIPHERAL SWELLING (non-serious), PAIN IN EXTREMITY (non-serious) all with onset 18Feb2021 17:00, outcome "recovered" (20Feb2021) and all described as "Inflamed sorearm"; CHILLS (non-serious) with onset 18Feb2021 17:00, outcome "recovered" (20Feb2021), described as "chills"; HYPERHIDROSIS (non-serious) with onset 19Feb2021 15:00, outcome "recovered" (20Feb2021), described as "sweats"; ERYTHEMA (non-serious), outcome "unknown", described as "Redness". Therapeutic measures were not taken as a result of headache, fatigue, peripheral swelling, chills, hyperhidrosis, pain in extremity.  Additional information: after 1st shot swelling was noted within 9 hours. Redness and soreness, increased insignificantly from top of arm to elbow 7 days afterwards peaking at about 9days and disappearance at about 11days.   No follow-up attempts are possible. No further information is expected.
12-25-2012 numbness in hands and feet. 12-26 numbness in legs, unable to walk - 12-27 admitted to hospital numbness up to chest - discharged on 12-30. 12-31 back in E.R. Transported via ambulance to med center - IV Gamma gobulin 1-5 tran regional rehab.
25SEP t102, sunburn gen rash all over;rash - h/a worse;started on 24SEP started w/mild itching & notices swelling & pain inj site;sl fever whole arm hurt & h/a;27SEP fever, h/a, & rash-rash x 3d;
I started out with sinus drainage and a tickle in my throat which developed into a cough. On 6/22/2022 I took an at home COVID-19 test that was positive. I developed a headache, fever, fatigue, and congestion. I felt like I had a cold. On 6/23/2022, I did a virtual visit and was prescribed Paxlovid. I have took Paxlovid since 6/23/2022 and today is my last day of Paxlovid. I still have lingering symptoms of fatigue.
flushing and different taste in mouth Narrative: Patient presented for 1st covid vaccine today. Ten minutes after vaccine patient felt flushed and reported a funny tast in his mouth. He denied any other neurological, respiratory or cardiac symptoms. He was kept for 40 minutes of monitoring. His symptoms improved and he was discharged in very good condition. His BP was 139/90 heart rate 75 and pulse ox 97%. He was encouraged to seek emergency tx if symptoms change with verbal understanding. Please follow up with patient. Patient returned call. Improved since COVID vaccine. No urgent medical attention needed from vaccination. Encouraged patient to share side effects experienced at next vaccine appt as covid clinic may request staying 30mins after injection. patient agreeable.
Black & blue from area of shot to elbow.  Hard where shot was given.  Pain but bearable.
Good reaction relating to modern vaccine/No longer in any pain/Turned off autoimmune overresponse/The vaccine caused an intense flair; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Good reaction relating to modern vaccine/No longer in any pain/Turned off autoimmune overresponse/The vaccine caused an intense flair) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder NOS.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Good reaction relating to modern vaccine/No longer in any pain/Turned off autoimmune overresponse/The vaccine caused an intense flair). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Good reaction relating to modern vaccine/No longer in any pain/Turned off autoimmune overresponse/The vaccine caused an intense flair) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
1/25 2021 immediately started sweating and blood pressure was elevated. At 2am couldnt feel legs and was rushed to ER with strok like symptoms, Brain Embolism was found which caused the stroke on left side . W as put in medical induced coma  . Coded and had seizures.  had to be intubated. released  from hospital on 2/2 .
Patient received her flu shot Thursday evening. She had some redness that evening so she iced for 15 minutes on/15 minutes off and that provided some relief. On Friday she felt more irritable nd the injection site was very tender. On Satruday the redness spread (several inches in diameter) and is hot to the touch. I advised her to speak with her doctor, continue to ice, and take Tylenol or Motrin as needed. She is seeing her doctor tomorrow for a different issue and will have them look at her arm as well. I advised her to see immediate medical care if it continues to spread.
G62.0 DRUG INDUCED POLYNEUROPATHY 9/1/2021 COLON CANCER, ASCENDING G62.9 PERIPHERAL NEUROPATHY 9/7/2021 COLON CANCER, ASCENDING I95.9 HYPOTENSION 9/20/2021 COLON CANCER, ASCENDING
Numbness and tingling (paresthesias) of upper and lower extremities: These symptoms came and went for a year, mostly pronounced at night when asleep and would wake me up in the middle of sleep because it became painful. Symptoms became less frequent by end of 2021 then re-emerged after booster dose on 12/17/21.  As of this writing,  I have a constant paresthesia of right middle finger. Paresthesia of lower extremities have subsided.
Dizziness, Headache, Myalgia, ErythemaMultiform, L arm pain,
Fully vaccinated, both initial shots with Moderna. Second Moderna shot caused "COVID arm," where I developed the large red area around the injection site a couple days post-shot. It was not raised or bumpy, just a large red area on the arm that was itchy. Went away after about 4-5 days.  Regarding my Moderna booster, I started feeling itchy all over, exactly 2 weeks post-booster, particularly on my scalp at first - very itchy to the point I started to wonder if I had lice or something, but then general itchiness all over my body. The next day, noticed hives and dermatographia, which I have never had before. I have had it ever since, with the "breakouts" just coming and going randomly throughout the day over different areas of my body - it has effected nearly all areas of my body (scalp, trunk, neck, hands, fingers, wrists, legs, ankles, behind ears, buttocks, pubic area, etc.). There have been 1-3 days, however, throughout this time that I have barely had any breakouts (thankfully), but most days it's pretty much picking which area to scratch all day long, as there will normally be multiple breakouts at once, making me wish I was an octopus with multiple arms to scratch all the different areas.
exhaustion, no energy, chills, shortness of breath, headache, muscle/body aches, runny nose, sinus congestion
100 bivalent boosters were given yesterday from vials that were put in the fridge and after that refrozen and thawed again; No adverse event; 100 bivalent boosters were given yesterday from vials that were put in the fridge and after that refrozen and thawed again; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (100 bivalent boosters were given yesterday from vials that were put in the fridge and after that refrozen and thawed again), PRODUCT STORAGE ERROR (100 bivalent boosters were given yesterday from vials that were put in the fridge and after that refrozen and thawed again) and NO ADVERSE EVENT (No adverse event) in an adult male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Jan-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 11-Jan-2023, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (100 bivalent boosters were given yesterday from vials that were put in the fridge and after that refrozen and thawed again). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (100 bivalent boosters were given yesterday from vials that were put in the fridge and after that refrozen and thawed again) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (100 bivalent boosters were given yesterday from vials that were put in the fridge and after that refrozen and thawed again), PRODUCT STORAGE ERROR (100 bivalent boosters were given yesterday from vials that were put in the fridge and after that refrozen and thawed again) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (100 bivalent boosters were given yesterday from vials that were put in the fridge and after that refrozen and thawed again) and PRODUCT STORAGE ERROR (100 bivalent boosters were given yesterday from vials that were put in the fridge and after that refrozen and thawed again).    This case contains information for the 93 of 100 patients described by the reporter.  No concomitant product was reported. No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-697752 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-697752:Master case
Symptoms are discomfort in genital area - 21mo saying "owie" and resisting diaper changes and baths. No visual redness or irritation noted by parent, aunt, teacher, nurses, or doctor. Issues occurred for parent and aunt for 2-3 days (Fri-Mon) before child reaction intensified (Monday PM) to the point of extreme crying & upset for 20-30 mins. Follow teacher confirmation of issues at daycare on Tuesday, and continued heightened reaction Tuesday PM , doctor's appt scheduled for Weds to investigate further.
This case was reported by a healthcare professional and described the occurrence of pain in a female subject aged 30-40's who was vaccinated with Fluarix, GlaxoSmithKline for prophylaxis.  On 9 October 2007 the subject received 1st dose of Fluarix 0.5 ml in the right arm.  On 9 October 2007, at an unspecified time after vaccination with Fluarix, the subject experienced pain.  At the time of reporting the outcome of the event was unspecified.  This event occurred in five different female subjects.
Patient received 1st dose of Pfizer in his left arm. Two minutes after receiving his dose he started to looked flushed. He states he has a headache and feels hot. 3 ice packs were used, one on head and two on neck/ shoulders. Blood pressure reading at 11:54am 229/150 Hg/mm, pulse 84 O2 98. His eyes were closing and he kept swaying at his right side. Patient states he has high blood pressure but unable to afford medication.  Asked to call 911. Blood pressure at 12:02pm 206/155 Hg/mm.  EMT Paramedics present on site, patient was transported via stretcher to near by hospital.  Entire team present at the site. Full in use.
pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnant) in a 33-year-old female patient (gravida 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 03-Oct-2020 and the estimated date of delivery was 09-Jul-2021. On 20-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-fourth week of the pregnancy.  On 20-Mar-2021, EXPOSURE DURING PREGNANCY (pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported No treatment medication was reported    Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: NNI
I have had COVID three times now/extremely sick again for the third time/this one is really bad like I can't breathe/I feel like crap; I have had COVID three times now/extremely sick again for the third time/this one is really bad like I can't breathe/I feel like crap; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "I have had COVID three times now/extremely sick again for the third time/this one is really bad like I can't breathe/I feel like crap". Clinical course: consumer stated, "I have had COVID three times now, as you can hear extremely sick again for the third time. I just want to report to you all that whenever, I mean I took flu shots (Unspecified Flu shot) I took all that kind of crap, I can keep naming all names of vaccine (Unspecified vaccine) that I took myself." Consumer added, "I would just like to kind of see the medical files on the COVID because like I said it is the third time that I have had it and this one is really bad like I can't breathe. So, I would like to see the medical files, whatever they have printed out, I want to see what the purpose of this vaccine (Pfizer COVID 19 Vaccine) is. I have had it three times now (COVID)." Consumer stated, "I would like to see it's on the medical records, printed. I would like to read the actual reports on the symptoms, treatment. I want everything." Consumer stated, "My husband is an oncologist, should I have my husband come after you instead because I feel like crap. All I want to see is the medical reports, that's all I want to see."  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient received 1st dose of COVID19 Pfizer on 29Jan2021, Patient received the 2nd dose on 08FEB2021. Patient received vaccine on day 10day and not on day 21-42.
Information has been received from a 20 year old female patient who on 07-AUG-2006 was vaccinated intramuscularly with her first dose of HPV rLi 6 11 16 18 VLP vaccine (yeast) (lot#653650/0702F).  Concomitant therapy included drospirenone (+) ethinyl estradiol (YAZ).  The patient stated that "right after getting the shot" she experienced pain in the upper arm on and off throughout the day.  She also stated that the pain"feels like she has a knife in her arm".  Unspecified medical attention was sought.  The patient was treated with Ibuprofen.  As of the report date, she was recovering.  Additional information has been requested.
pt recvd vax & devel guillain barre synd; tx w/ IV IGG, condition persists;
Pt reported dizziness to EMT at 1200. EMT assessed pt. BP: 110/80. Pt reported hx of allergic reactions to bees and peanuts. Pt offered Diphenhydramine at 1220. Pt denied diphenhydramine. Pt advised to wait an extra 15 minutes for observation. Pt's symptoms resolved within 15 minutes. Pt left facility at 1235 with steady gait.
This spontaneous report was received from a registered nurse refers to an unspecified number of unspecified patients received of unknown age and gender. The patient's medical history and concurrent conditions and concomitant medications were not specified. On an unknown date, the patients were vaccinated with doses of improperly stored (Oka/Merck) VARIVAX (lot number, expiration date, dose, frequency and route of administration not specified). No adverse effect reported. The outcome of the events was unknown. No product quality complaint (PQC) was involved. This is one of two reports received from the same reporter. Additional information has been requested.
Sinus symptoms and also reflux symptoms. I had these for two days.  I took Benadryl; a day off from work and then I had the weekend off to recover. - I had a doctor visit - telephone consult
Within 12 hours of the vaccine developed 102 fever, chills, headache, body ache, nausea, fatigue, and shortness of breath.  Lasted through the night.  Next two days fever of 101.4,  headache, fatigue, nausea continued.  After three days most symptoms ended with the exception of fatigue, general malaise, periods of mild headache.  Almost two weeks later and still dealing with general malaise, occasional headache and fatigue.
Pain in arm, redness, pt seen 11/3/06 Tylenol, ice PRN, symptoms resolved after few days. Pt contacted by office 11/06/06, symptoms were almost resolved.
Patient calls this morning saying she woke up yesterday with a sore throat. She began taking oral typhoid vaccine as directed on 3/5/08 and took doses on 3/7, 3/9 and 3/11. Woke up with the sore throat on 3/11 but reports she has been generally fatigued since she began taking the Vivotif vaccine. She reports she also had a fever of 101 degrees yesterday.  I told patient it is possible this is connected with typhoid but that there also are several bad viral illnesses going around. Counseled patient that if she is having trouble swallowing or breathing, or is having spiking fevers, nausea/vomiting or not getting better after a few days she needs to contact her PCP of if more worrisome symptoms go to ER. Patient expresses understanding.   Had MA call patient on Monday, 3/17. Patient reported she was still having the sore throat with moderating fever and she had scheduled appointment with her PCP.   3/27/08   Note that I left message with patient on Friday 3/21/08 asking her to call us back and tell us how she is doing and report on her visit with her PCP.  Have not heard back from her.
This case was reported by a nurse and described the occurrence of hepatitis b antibody negative in a subject of unspecified age and gender who was vaccinated with Engerix-B for prophylaxis. Concurrent medical conditions included hemodialysis. On three unspecified dates on or prior to 30 August 2006, the subject received three doses of Engerix-B in hemodialysis subjects is four doses of the vaccine, administered on a 0,1, 2, and 6 month dosing schedule. After receiving the three doses of Engerix-B, the subject tested negative for antibody to hepatitis B. The nurse stated that she planned to administer an Engerix-B booster dose to the subject and check titer levels approximately six weeks after the booster was administered. No additional information was reported regarding this event. At the time of reporting the outcome of the event was unspecified.
Flu vaccine administered into left deltoid 11/18/2011. Employee states she noted erythema & swelling at site a short while after administration at home. Evaluated on Monday 11/21/2011 by employee health & pt sent to emergency room. Afebrile, warmth & redness & swelling at site of admin.